Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03708224
Title Phase II Study of Perioperative Immunotherapy in Patients With Advanced Non-Virally Associated Squamous Cell Carcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco

oropharynx cancer

nasopharynx carcinoma

head and neck squamous cell carcinoma


Atezolizumab + Emactuzumab


Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.